Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
MORGAN STANLEY
> NTLA
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Intellia Therapeutics, Inc. | NTLA | 2,849,207 | 331,057 | 116,190,677,000 | 28,332,425,000 | $40,780.01 |
12/31/2022 | Intellia Therapeutics, Inc. | NTLA | 2,518,150 | 987,599 | 87,858,252,000 | 87,772,602,000 | $34,890.00 |
09/30/2022 | Intellia Therapeutics, Inc. | NTLA | 1,530,551 | 294,357 | 85,650,000 | 21,666,000 | $55.96 |
06/30/2022 | Intellia Therapeutics, Inc. | NTLA | 1,236,194 | -58,805 | 63,984,000 | -30,125,000 | $51.76 |
03/31/2022 | Intellia Therapeutics, Inc. | NTLA | 1,294,999 | -228,254 | 94,109,000 | -86,001,000 | $72.67 |
12/31/2021 | Intellia Therapeutics, Inc. | NTLA | 1,523,253 | 377,214 | 180,110,000 | 26,368,000 | $118.24 |
09/30/2021 | Intellia Therapeutics, Inc. | NTLA | 1,146,039 | 448,316 | 153,742,000 | 40,774,000 | $134.15 |
06/30/2021 | Intellia Therapeutics, Inc. | NTLA | 697,723 | 192,393 | 112,968,000 | 72,414,000 | $161.91 |
03/31/2021 | Intellia Therapeutics, Inc. | NTLA | 505,330 | -671,125 | 40,554,000 | -23,444,000 | $80.25 |
12/31/2020 | Intellia Therapeutics, Inc. | NTLA | 1,176,455 | -10,378 | 63,998,000 | 40,403,000 | $54.40 |
09/30/2020 | Intellia Therapeutics, Inc. | NTLA | 1,186,833 | 406,842 | 23,595,000 | 7,199,000 | $19.88 |
06/30/2020 | Intellia Therapeutics, Inc. | NTLA | 779,991 | 131,139 | 16,396,000 | 8,461,000 | $21.02 |
03/31/2020 | Intellia Therapeutics, Inc. | NTLA | 648,852 | -303,414 | 7,935,000 | -6,035,000 | $12.23 |
12/31/2019 | Intellia Therapeutics, Inc. | NTLA | 952,266 | 29,879 | 13,970,000 | 1,656,000 | $14.67 |
09/30/2019 | Intellia Therapeutics, Inc. | NTLA | 922,387 | 33,126 | 12,314,000 | -2,243,000 | $13.35 |
06/30/2019 | Intellia Therapeutics, Inc. | NTLA | 889,261 | -1,075,202 | 14,557,000 | -18,995,000 | $16.37 |
03/31/2019 | Intellia Therapeutics, Inc. | NTLA | 1,964,463 | -267,783 | 33,552,000 | 3,082,000 | $17.08 |
12/31/2018 | Intellia Therapeutics, Inc. | NTLA | 2,232,246 | 262,189 | 30,470,000 | -25,914,000 | $13.65 |
09/30/2018 | Intellia Therapeutics, Inc. | NTLA | 1,970,057 | -264,242 | 56,384,000 | -4,745,000 | $28.62 |
06/30/2018 | Intellia Therapeutics, Inc. | NTLA | 2,234,299 | 324,280 | 61,129,000 | 20,847,000 | $27.36 |
03/31/2018 | Intellia Therapeutics, Inc. | NTLA | 1,910,019 | 1,581,092 | 40,282,000 | 33,960,000 | $21.09 |
12/31/2017 | Intellia Therapeutics, Inc. | NTLA | 328,927 | 39,559 | 6,322,000 | -868,000 | $19.22 |
09/30/2017 | Intellia Therapeutics, Inc. | NTLA | 289,368 | 77,843 | 7,190,000 | 7,187,020 | $24.85 |
03/31/2017 | Intellia Therapeutics, Inc. | NTLA | 211,525 | -33,955 | 2,980 | -3,215,020 | $0.01 |
12/31/2016 | Intellia Therapeutics, Inc. | NTLA | 245,480 | -37,346 | 3,218,000 | -1,596,000 | $13.11 |
09/30/2016 | Intellia Therapeutics, Inc. | NTLA | 282,826 | 282,826 | 4,814,000 | 4,814,000 | $17.02 |
06/30/2016 | Intellia Therapeutics, Inc. | NTLA | 301,358 | 301,358 | 6,434,000 | 6,434,000 | $21.35 |
<< Prev Next >> |
|